Department of Biomaterials and Biomimetics, New York University College of Dentistry, New York, New York.
Department of Periodontology, University of Florida in Gainesville, Gainesville, Florida.
J Biomed Mater Res B Appl Biomater. 2019 Jul;107(5):1320-1328. doi: 10.1002/jbm.b.34225. Epub 2018 Sep 10.
The study evaluated the effects of a Supercritical CO (scCO ) on a commercially available decellularized/delipidized naturally derived porcine pericardium collagen membrane, Vitala®. The Vitala® and scCO treated experimental membranes were evaluated for guided tissue regeneration (GTR) of periodontal tissue in class III furcation defects utilizing a dog model. Physical material characterization was performed by scanning electron microscopy (SEM), thermogravimetric analysis (TGA), and differential scanning calorimetry (DSC). The in vivo portion of the study was allocated to three-time points (6, 12, and 24-weeks) using standardized class III furcation defects created in the upper second and third premolars. The experimental defects (n = 5) were covered with either a collagen membrane (positive control), scCO -treated collagen membrane (experimental) or no membrane (negative control). Following sacrifice, histologic serial sections were performed from cervical to apical for morphologic/morphometric evaluation. Morphometric evaluation was carried out by ranking the presence of collagen membrane, amount of bone formation within the defect site and inflammatory cell infiltrate content. SEM showed the experimental scCO -treated membrane to have a similar gross fibrous appearance and chemical structure in comparison to the Vitala® Collagen membrane. A significant increase in membrane thickness was noted in the scCO -treated membranes (366 ± 54 μm) vs non-treated membranes (265 ± 75 μm). TGA and DSC spectra indicated no significant qualitative differences between the two membranes. For the in vivo results, both membranes indicated significantly greater amounts of newly formed bone (scCO : 2.85 ± 1.1; Vitala®: 2.80 ± 1.0) within the covered defects relative to uncovered controls (0.8 ± 0.27) at 24 weeks. Both membrane types gradually degraded as time elapsed in vivo from 6 to 12 weeks, and presented nearly complete resorption at 24 weeks. The inflammatory infiltrate at regions in proximity with the membranes was commensurate with healthy tissue levels from 6 weeks in vivo on, and periodontal ligament regeneration onset was detected at 12 weeks in vivo. The effect of the supplementary scCO treatment step on the collagen membrane was demonstrated to be biocompatible, allowing for the infiltration of cells and degradation over time. The treated membranes presented similar performance in GTR to non-treated samples in Class III furcation lesions. Defects treated without membranes failed to achieve regeneration of the native periodontium. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 1320-1328, 2019.
该研究评估了超临界 CO(scCO)对一种市售脱细胞/脱脂天然猪心包胶原膜 Vitala®的影响。利用犬模型,将 Vitala®和 scCO 处理的实验膜评估用于牙周组织引导组织再生(GTR)的牙周组织。通过扫描电子显微镜(SEM)、热重分析(TGA)和差示扫描量热法(DSC)进行物理材料特性分析。体内部分研究分为三个时间点(6、12 和 24 周),在上颌第二和第三前磨牙中创建标准的 III 类分叉缺损。实验性缺损(n=5)用胶原膜(阳性对照)、scCO 处理的胶原膜(实验)或无膜(阴性对照)覆盖。在牺牲后,从颈部到根尖进行组织学连续切片,进行形态/形态计量学评估。形态计量学评估通过对胶原膜的存在、缺损部位骨形成量和炎症细胞浸润含量进行分级来进行。SEM 显示,与 Vitala®胶原膜相比,实验性 scCO 处理的膜具有相似的大体纤维外观和化学结构。在 scCO 处理的膜(366±54μm)与未处理的膜(265±75μm)之间,膜厚度显著增加。TGA 和 DSC 谱表明,两种膜之间没有明显的定性差异。对于体内结果,两种膜均显示覆盖缺陷内形成的新骨量显著增加(scCO:2.85±1.1;Vitala®:2.80±1.0),与未覆盖对照(0.8±0.27)相比,在 24 周时。两种膜类型都随着时间的推移在体内从 6 周逐渐降解,并在 24 周时几乎完全吸收。在膜附近的区域,炎症浸润与体内 6 周时的健康组织水平相当,并在体内 12 周时检测到牙周韧带再生开始。补充的 scCO 处理步骤对胶原膜的影响被证明是生物相容的,允许细胞渗透和随时间降解。在 III 类分叉缺损中,处理过的膜在 GTR 中的表现与未经处理的样品相似。未用膜治疗的缺陷未能实现天然牙周组织的再生。2018 年 Wiley 期刊,生物医学材料研究杂志 B:应用生物材料 107B:1320-1328,2019 年。